Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Connors

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Biochemical Pharmacology|May 1, 1972
Observations on the metabolism of cyclophosphamideT A Connors, A B Foster, A M Gilsenan, et al.
Biochemical Pharmacology|August 1, 1973
Studies on the mechanism of action of the tumour inhibitory triazenesR C Audette, T A Connors, H G Mandel, et al.
British Journal of Cancer|November 11, 1999
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeuticsD R Newell, S S Burtles, B W Fox, et al.
European Journal of Cancer|January 1, 1973
The selective concentration of sulphadiazine and related compounds in malignant tissueG Abel, T A Connors, W C Ross, et al.
Toxicology and Applied Pharmacology|January 1, 1985
In vitro covalent binding of cismethrin, bioresmethrin, and their common alcohol to hepatic proteinsH Hoellinger, M Sonnier, A J Gray, et al.
Cancer Treatment Reports|August 1, 1977
Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamineT A Connors, A J Cumber, W C Ross, et al.
Cancer Treatment Reports|May 1, 1977
Chemotherapy of human tumors in T-lymphocyte-deficient miceB C Mitchley, S A Clarke, T A Connors, et al.
Carcinogenesis|November 1, 1989
Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell linesI N White, M Suzanger, A R Mattocks, et al.
Biochemical Pharmacology|August 15, 1973
Metabolism of aniline mustard (N,N-di-(2-chloroethyl)aniline)T A Connors, P B Farmer, A B Foster, et al.
Biomedical Mass Spectrometry|April 1, 1974
Observations on the mechanism of hydroxylation of cyclophosphamide by rat liver microsomes: the metabolism of cyclophosphamide-4-d2T A Connors, P J Cox, P B Farmer, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|May 1, 1972
Observations on the metabolism of cyclophosphamideT A Connors, A B Foster, A M Gilsenan, et al.
Biochemical Pharmacology|August 1, 1973
Studies on the mechanism of action of the tumour inhibitory triazenesR C Audette, T A Connors, H G Mandel, et al.
British Journal of Cancer|November 11, 1999
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeuticsD R Newell, S S Burtles, B W Fox, et al.
European Journal of Cancer|January 1, 1973
The selective concentration of sulphadiazine and related compounds in malignant tissueG Abel, T A Connors, W C Ross, et al.
Toxicology and Applied Pharmacology|January 1, 1985
In vitro covalent binding of cismethrin, bioresmethrin, and their common alcohol to hepatic proteinsH Hoellinger, M Sonnier, A J Gray, et al.
Cancer Treatment Reports|August 1, 1977
Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamineT A Connors, A J Cumber, W C Ross, et al.
Cancer Treatment Reports|May 1, 1977
Chemotherapy of human tumors in T-lymphocyte-deficient miceB C Mitchley, S A Clarke, T A Connors, et al.
Carcinogenesis|November 1, 1989
Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell linesI N White, M Suzanger, A R Mattocks, et al.
Biochemical Pharmacology|August 15, 1973
Metabolism of aniline mustard (N,N-di-(2-chloroethyl)aniline)T A Connors, P B Farmer, A B Foster, et al.
Biomedical Mass Spectrometry|April 1, 1974
Observations on the mechanism of hydroxylation of cyclophosphamide by rat liver microsomes: the metabolism of cyclophosphamide-4-d2T A Connors, P J Cox, P B Farmer, et al.
Pageof 8